Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Erdafitinib 8, urinary Bladder Cancer

Protocol-ID: 2001 V1.0 (Mini), ERDA8, Bladder Cancer

Indication(s)

  • Bladder Cancer (FGFR2/3 Fusion, FGFR3 Mutation); ICD-10 C67.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 18.03.2022